相关实验视频

Updated: May 7, 2025

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

一种可诱导的神经干细胞原始细胞模型,用于测试对神经退行症的治疗干预措施 FENIB

Alessandro Giustini¹, Alice Maiocchi², Ilaria Serangeli¹

¹Department of Biology and Biotechnologies 'Charles Darwin', Sapienza University of Rome, Rome, Italy.

Drug development research

|January 3, 2025

概括

研究人员开发了一种新的细胞模型,用于神经含体 (FENIB) 的家族脑病. 这种使用神经干细胞的模型将有助于发现由突变神经素 (NS) 积累引起的神经退行性疾病的治疗方法.

科学领域:

神经科学是一个神经科学.
细胞生物学细胞生物学
遗传学是一个遗传学.

背景情况:

带有神经塞尔体的家族脑病变 (FENIB) 是一种致命的神经退行性疾病.
由突变神经胺 (NS) 聚合物在神经元内质网膜 (ER) 中的积累引起.
目前的治疗方法是息的,这凸显了新的治疗策略的需要.

研究的目的:

建立一个用于FENIB药物发现的新型细胞培养系统.
创建一个用于选减少神经胺 (NS) 聚合物形成的小分子的模型.

主要方法:

生成的神经干细胞原生细胞 (NPC) 具有诱导性表达的野生类型 (WT) 或G392E突变神经素 (NS).
利用这些细胞系来测试四种蛋白质分解向奇美拉 (PROTAC) 化合物.
PROTACs的设计是为了通过E3的ubiquitin结合酶脑来向突变NS进行蛋白质体降解.

主要成果:

成功生成并表征了用于FENIB建模的新型诱导NPC细胞系.
经过测试的PROTAC化合物显示出最小的毒性,并且没有改变NS水平.
在测试的PROTACs中没有观察到NS聚合物形成的显著减少.

结论:

开发的细胞模型为未来的FENIB治疗研究提供了一个平台.
这项研究为识别防止ER NS积累的分子奠定了基础.
可能需要进一步优化PROTACs或替代策略来准突变NS降解.

关键词:

法尼布 (FENIB) 是一个国际组织.这就是PROTAC.这就是为什么Cereblon.艾姆贝林是个美丽的人.神经前代细胞的神经前代细胞这是一种神经神经神经.

更多相关视频

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

Published on: July 29, 2015

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...